According to this latest study, the 2021 growth of Adipose Tissue-derived Stem Cell Therapy will have significant change from previous year. By the most conservative estimates of global Adipose Tissue-derived Stem Cell Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Adipose Tissue-derived Stem Cell Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Adipose Tissue-derived Stem Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Autologous Stem Cells

Allogeneic Stem Cells

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Therapeutic Application

Research Application

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

AlloCure

Antria

Celgene Corporation

Cellleris

Corestem

Cytori Therapeutics

Intrexon

Mesoblast

Pluristem Therapeutics

Tissue Genesis

BioRestorative Therapies

Celltex Therapeutics Corporation

iXCells Biotechnologies

Pluristem Therapeutics

Cyagen

Lonza

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size 2016-2026

2.1.2 Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Adipose Tissue-derived Stem Cell Therapy Segment by Type

2.2.1 Autologous Stem Cells

2.2.2 Autologous Stem Cells

2.3 Adipose Tissue-derived Stem Cell Therapy Market Size by Type

2.3.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Type

2.3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2016-2021)

2.4 Adipose Tissue-derived Stem Cell Therapy Segment by Application

2.4.1 Therapeutic Application

2.4.2 Research Application

2.5 Adipose Tissue-derived Stem Cell Therapy Market Size by Application

2.5.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Application

2.5.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2016-2021)

3 Adipose Tissue-derived Stem Cell Therapy Market Size by Players

3.1 Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Players

3.1.1 Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2019-2021E)

3.1.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2019-2021E)

3.2 Global Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Adipose Tissue-derived Stem Cell Therapy by Regions

4.1 Adipose Tissue-derived Stem Cell Therapy Market Size by Regions (2016-2021)

4.2 Americas Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2016-2021)

4.3 APAC Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2016-2021)

4.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2016-2021)

4.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2016-2021)

5 Americas

5.1 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021)

5.2 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)

5.3 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2016-2021)

6.2 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)

6.3 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Adipose Tissue-derived Stem Cell Therapy by Country (2016-2021)

7.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)

7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy by Region (2016-2021)

8.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021)

8.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.1 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Regions (2021-2026)

10.1.1 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Regions (2021-2026)

10.1.2 Americas Adipose Tissue-derived Stem Cell Therapy Forecast

10.1.3 APAC Adipose Tissue-derived Stem Cell Therapy Forecast

10.1.4 Europe Adipose Tissue-derived Stem Cell Therapy Forecast

10.1.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Forecast

10.2 Americas Adipose Tissue-derived Stem Cell Therapy Forecast by Countries (2021-2026)

10.2.1 United States Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.2.2 Canada Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.2.3 Mexico Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.2.4 Brazil Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3 APAC Adipose Tissue-derived Stem Cell Therapy Forecast by Region (2021-2026)

10.3.1 China Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.2 Japan Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.3 Korea Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.4 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.5 India Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.3.6 Australia Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4 Europe Adipose Tissue-derived Stem Cell Therapy Forecast by Country (2021-2026)

10.4.1 Germany Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4.2 France Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4.3 UK Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4.4 Italy Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.4.5 Russia Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Forecast by Region (2021-2026)

10.5.1 Egypt Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5.2 South Africa Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5.3 Israel Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5.4 Turkey Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.5.5 GCC Countries Adipose Tissue-derived Stem Cell Therapy Market Forecast

10.6 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Type (2021-2026)

10.8 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 AlloCure

11.1.1 AlloCure Company Information

11.1.2 AlloCure Adipose Tissue-derived Stem Cell Therapy Product Offered

11.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 AlloCure Main Business Overview

11.1.5 AlloCure Latest Developments

11.2 Antria

11.2.1 Antria Company Information

11.2.2 Antria Adipose Tissue-derived Stem Cell Therapy Product Offered

11.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Antria Main Business Overview

11.2.5 Antria Latest Developments

11.3 Celgene Corporation

11.3.1 Celgene Corporation Company Information

11.3.2 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered

11.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Celgene Corporation Main Business Overview

11.3.5 Celgene Corporation Latest Developments

11.4 Cellleris

11.4.1 Cellleris Company Information

11.4.2 Cellleris Adipose Tissue-derived Stem Cell Therapy Product Offered

11.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Cellleris Main Business Overview

11.4.5 Cellleris Latest Developments

11.5 Corestem

11.5.1 Corestem Company Information

11.5.2 Corestem Adipose Tissue-derived Stem Cell Therapy Product Offered

11.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Corestem Main Business Overview

11.5.5 Corestem Latest Developments

11.6 Cytori Therapeutics

11.6.1 Cytori Therapeutics Company Information

11.6.2 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

11.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Cytori Therapeutics Main Business Overview

11.6.5 Cytori Therapeutics Latest Developments

11.7 Intrexon

11.7.1 Intrexon Company Information

11.7.2 Intrexon Adipose Tissue-derived Stem Cell Therapy Product Offered

11.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Intrexon Main Business Overview

11.7.5 Intrexon Latest Developments

11.8 Mesoblast

11.8.1 Mesoblast Company Information

11.8.2 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Offered

11.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Mesoblast Main Business Overview

11.8.5 Mesoblast Latest Developments

11.9 Pluristem Therapeutics

11.9.1 Pluristem Therapeutics Company Information

11.9.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

11.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Pluristem Therapeutics Main Business Overview

11.9.5 Pluristem Therapeutics Latest Developments

11.10 Tissue Genesis

11.10.1 Tissue Genesis Company Information

11.10.2 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Offered

11.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Tissue Genesis Main Business Overview

11.10.5 Tissue Genesis Latest Developments

11. BioRestorative Therapies

11.11.1 BioRestorative Therapies Company Information

11.11.2 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Offered

11.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 BioRestorative Therapies Main Business Overview

11.11.5 BioRestorative Therapies Latest Developments

11.12 Celltex Therapeutics Corporation

11.12.1 Celltex Therapeutics Corporation Company Information

11.12.2 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered

11.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Celltex Therapeutics Corporation Main Business Overview

11.12.5 Celltex Therapeutics Corporation Latest Developments

11.13 iXCells Biotechnologies

11.13.1 iXCells Biotechnologies Company Information

11.13.2 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Offered

11.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 iXCells Biotechnologies Main Business Overview

11.13.5 iXCells Biotechnologies Latest Developments

11.14 Pluristem Therapeutics

11.14.1 Pluristem Therapeutics Company Information

11.14.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

11.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Pluristem Therapeutics Main Business Overview

11.14.5 Pluristem Therapeutics Latest Developments

11.15 Cyagen

11.15.1 Cyagen Company Information

11.15.2 Cyagen Adipose Tissue-derived Stem Cell Therapy Product Offered

11.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Cyagen Main Business Overview

11.15.5 Cyagen Latest Developments

11.16 Lonza

11.16.1 Lonza Company Information

11.16.2 Lonza Adipose Tissue-derived Stem Cell Therapy Product Offered

11.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Lonza Main Business Overview

11.16.5 Lonza Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Autologous Stem Cells

Table 3. Major Players of Allogeneic Stem Cells

Table 4. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2016-2021)

Table 7. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 8. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 9. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2016-2021)

Table 10. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2019-2021E) & ($ Millions)

Table 11. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2019-2021E)

Table 12. Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Products Offered

Table 13. Adipose Tissue-derived Stem Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions 2016-2021 & ($ Millions)

Table 17. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions 2016-2021

Table 18. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021) & ($ Millions)

Table 19. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country (2016-2021)

Table 20. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 21. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2016-2021)

Table 22. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 23. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2016-2021)

Table 24. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2016-2021) & ($ Millions)

Table 25. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region (2016-2021)

Table 26. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 27. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2016-2021)

Table 28. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 29. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2016-2021)

Table 30. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2016-2021) & ($ Millions)

Table 31. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country (2016-2021)

Table 32. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 33. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2016-2021)

Table 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2016-2021)

Table 36. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2016-2021) & ($ Millions)

Table 37. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region (2016-2021)

Table 38. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2016-2021)

Table 40. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2016-2021)

Table 42. Key and Potential Regions of Adipose Tissue-derived Stem Cell Therapy

Table 43. Key Application and Potential Industries of Adipose Tissue-derived Stem Cell Therapy

Table 44. Key Challenges of Adipose Tissue-derived Stem Cell Therapy

Table 45. Key Trends of Adipose Tissue-derived Stem Cell Therapy

Table 46. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 47. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Regions (2021-2026)

Table 48. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 49. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Type (2021-2026)

Table 50. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 51. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Application (2021-2026)

Table 52. AlloCure Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 53. AlloCure Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 54. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 55. AlloCure Main Business

Table 56. AlloCure Latest Developments

Table 57. Antria Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 58. Antria Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 59. Antria Main Business

Table 60. Antria Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 61. Antria Latest Developments

Table 62. Celgene Corporation Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 63. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 64. Celgene Corporation Main Business

Table 65. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Celgene Corporation Latest Developments

Table 67. Cellleris Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 68. Cellleris Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 69. Cellleris Main Business

Table 70. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Cellleris Latest Developments

Table 72. Corestem Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 73. Corestem Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 74. Corestem Main Business

Table 75. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. Corestem Latest Developments

Table 77. Cytori Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 78. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 79. Cytori Therapeutics Main Business

Table 80. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Cytori Therapeutics Latest Developments

Table 82. Intrexon Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 83. Intrexon Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 84. Intrexon Main Business

Table 85. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. Intrexon Latest Developments

Table 87. Mesoblast Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 88. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 89. Mesoblast Main Business

Table 90. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. Mesoblast Latest Developments

Table 92. Pluristem Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 93. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 94. Pluristem Therapeutics Main Business

Table 95. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 96. Pluristem Therapeutics Latest Developments

Table 97. Tissue Genesis Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 98. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 99. Tissue Genesis Main Business

Table 100. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 101. Tissue Genesis Latest Developments

Table 102. BioRestorative Therapies Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 103. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 104. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 105. BioRestorative Therapies Main Business

Table 106. BioRestorative Therapies Latest Developments

Table 107. Celltex Therapeutics Corporation Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 108. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 109. Celltex Therapeutics Corporation Main Business

Table 110. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 111. Celltex Therapeutics Corporation Latest Developments

Table 112. iXCells Biotechnologies Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 113. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 114. iXCells Biotechnologies Main Business

Table 115. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 116. iXCells Biotechnologies Latest Developments

Table 117. Pluristem Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 118. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 119. Pluristem Therapeutics Main Business

Table 120. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 121. Pluristem Therapeutics Latest Developments

Table 122. Cyagen Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 123. Cyagen Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 124. Cyagen Main Business

Table 125. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 126. Cyagen Latest Developments

Table 127. Lonza Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors

Table 128. Lonza Adipose Tissue-derived Stem Cell Therapy Product Offered

Table 129. Lonza Main Business

Table 130. Lonza Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 131. Lonza Latest Developments

List of Figures

Figure 1. Adipose Tissue-derived Stem Cell Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2020

Figure 7. Adipose Tissue-derived Stem Cell Therapy in Therapeutic Application

Figure 8. Global Adipose Tissue-derived Stem Cell Therapy Market: Therapeutic Application (2016-2021) & ($ Millions)

Figure 9. Adipose Tissue-derived Stem Cell Therapy in Research Application

Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Market: Research Application (2016-2021) & ($ Millions)

Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2020

Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Player in 2020

Figure 13. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions (2016-2021)

Figure 14. Americas Adipose Tissue-derived Stem Cell Therapy Market Size 2016-2021 ($ Millions)

Figure 15. APAC Adipose Tissue-derived Stem Cell Therapy Market Size 2016-2021 ($ Millions)

Figure 16. Europe Adipose Tissue-derived Stem Cell Therapy Market Size 2016-2021 ($ Millions)

Figure 17. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2016-2021 ($ Millions)

Figure 18. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country in 2020

Figure 19. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2020

Figure 20. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2020

Figure 21. United States Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 22. Canada Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 23. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 24. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions in 2020

Figure 25. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2020

Figure 26. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2020

Figure 27. China Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 28. Japan Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 29. Korea Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 30. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 31. India Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 32. Australia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 33. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country in 2020

Figure 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2020

Figure 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2020

Figure 36. Germany Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 37. France Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 38. UK Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 39. Italy Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 40. Russia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region in 2020

Figure 42. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2020

Figure 43. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2020

Figure 44. Egypt Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 45. South Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 46. Israel Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 47. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 48. GCC Country Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2016-2021 ($ Millions)

Figure 49. Americas Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 50. APAC Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 51. Europe Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 52. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 53. United States Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 54. Canada Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 55. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 56. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 57. China Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 58. Japan Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 59. Korea Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 60. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 61. India Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 62. Australia Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 63. Germany Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 64. France Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 65. UK Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 66. Italy Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 67. Russia Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 68. Spain Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 69. Egypt Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 70. South Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 71. Israel Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 72. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)

Figure 73. GCC Country Adipose Tissue-derived Stem Cell Therapy Market Size 2021-2026 ($ Millions)